ArticleNPJ vaccines2022

Development of an attenuated vaccine against Koi Herpesvirus Disease (KHVD) suitable for oral administration and immersion.

Sandro Klafack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.